CLOSTRABIO

ClostraBio is dedicated to creating new dietary supplements and therapeutics to treat gut health, inflammatory bowel disease (IBD), and food allergy... The ClostraBio team is developing both a dietary supplement and a plug-n-play platform for delivery of bacterial metabolites to target gut health... With IND-enabling toxicology studies underway, we expect to initiate clinical studies in the near future. Given the expected favorable safety profile of our compounds, we intend to enroll patients with mild-moderate ulcerative colitis (UC) in a Phase 1a/b SAD-MAD clinical study to obtain safety/tolerability data, determine our Phase 2 dose, and generate exploratory efficacy endpoints.

Also known as: ClostraBio, Inc.